HCG 5000IU
HCG 5000IU
Human Chorionic Gonadotropin — essential for maintaining testicular function on-cycle and during PCT.
Save 10% when you pay in crypto (BTC · ETH · USDT)
Free shipping on orders over $250
Research use only. Products are not intended for human consumption.
We accept
Interac e-Transfer · BTC · ETH · USDT crypto −10%
How ordering works
- 01Place your order — no payment is taken on this site.
- 02Payment instructions arrive by email reply (Interac e-Transfer or crypto).
- 03Paid before 4 PM EST → same-day dispatch with tracking number.
Refrigerated SKU? Ships in an insulated cold-pack mailer. You receive a packaging photograph within 4 hours of dispatch.
- Janoshik verified — per-batch third-party purity testing
- Discreet — plain packaging, no brand markings
- Cold-pack mailer for refrigerated SKUs
- Refund + retest if a batch fails purity
Complete protocols
Build your stack
Stacks that include HCG 5000IU — protocol components priced together, bulk savings applied automatically.
At a glance
At a glance
- Concentration
- 5000 IU
- Purity
- 99.5%+
- Route
- Subcutaneous injection
- Storage
- Lyophilized: room temperature, desiccated. Reconstituted: 2–8°C, ≤30 days.
Compound profile
Human Chorionic Gonadotropin (HCG) is a 237-amino-acid heterodimeric glycoprotein hormone composed of an alpha subunit (shared with LH, FSH, and TSH) and a unique beta subunit that confers its biological specificity. HCG is naturally produced by trophoblast cells of the placenta during pregnancy, but its research significance lies in its near-identical structural and functional homology with luteinizing hormone (LH). HCG binds to and activates the LH/CG receptor on Leydig cells in the testes, directly stimulating testosterone biosynthesis through the cholesterol side-chain cleavage pathway, independent of the hypothalamic-pituitary axis.
Human Chorionic Gonadotropin (HCG) is a 237-amino-acid heterodimeric glycoprotein hormone composed of an alpha subunit (shared with LH, FSH, and TSH) and a unique beta subunit that confers its biological specificity. HCG is naturally produced by trophoblast cells of the placenta during pregnancy, but its research significance lies in its near-identical structural and functional homology with luteinizing hormone (LH). HCG binds to and activates the LH/CG receptor on Leydig cells in the testes, directly stimulating testosterone biosynthesis through the cholesterol side-chain cleavage pathway, independent of the hypothalamic-pituitary axis.
HCG's mechanism at the testicular level bypasses the HPG axis entirely. By directly binding LH receptors on Leydig cells, it activates adenylyl cyclase, increases cAMP, and upregulates the steroidogenic acute regulatory protein (StAR) that transports cholesterol into mitochondria for conversion to pregnenolone — the rate-limiting step in testosterone synthesis. This direct Leydig cell stimulation maintains intratesticular testosterone (ITT) at levels necessary for spermatogenesis, testicular volume, and Leydig cell viability even when exogenous androgen use has suppressed LH secretion from the pituitary. Without LH receptor stimulation, Leydig cells undergo progressive desensitization and atrophy, making HCG essential for preserving testicular function during protocols that suppress endogenous gonadotropins.
Research consistently demonstrates that HCG maintains testicular size, preserves intratesticular testosterone concentrations, supports spermatogenesis, and facilitates faster recovery of endogenous testosterone production when exogenous androgens are discontinued. It is the standard of care for preventing testicular atrophy during testosterone replacement therapy and is a foundational component of post-cycle therapy (PCT) protocols, where it is typically used as a "bridge" between the cessation of suppressive compounds and the initiation of SERM-based recovery.
HCG is suited for researchers investigating testicular function maintenance, HPG axis recovery, intratesticular testosterone dynamics, and reproductive hormone optimization. It is an essential compound for any research protocol involving suppressive hormonal compounds.
Reconstitute the 5000IU vial with 2.5ml bacteriostatic water (yielding 2000IU/ml). Administer via subcutaneous or intramuscular injection. On-cycle research dosing typically ranges from 250-500IU every other day or twice weekly. PCT bridge dosing may use 1000-1500IU every other day for 2-3 weeks before transitioning to SERMs. HCG has a half-life of approximately 24-36 hours. Store reconstituted solution at 2-8C and use within 30 days — HCG is a large glycoprotein that degrades relatively quickly in solution. Do not freeze reconstituted HCG. The lyophilized powder should be refrigerated.
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
HCG 5000IU is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water (BAC water) before use in a research setting.
- Clean the BAC water vial stopper and the peptide vial stopper with an alcohol swab. Allow to dry.
- Draw the required volume of BAC water into a sterile syringe (typically 1–3 mL depending on target concentration).
- Angle the needle so the water runs down the inside wall of the peptide vial. Avoid dispensing directly onto the powder.
- Do not shake. Gently swirl or roll until fully dissolved. Vigorous shaking can denature peptides.
- Refrigerate reconstituted solution at 2–8°C. Most reconstituted peptides are stable 14–30 days depending on compound.
Target concentration determines drawing volume. For dosing math, consult the dosing math guide.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
At a glance
At a glance
- Concentration
- 5000 IU
- Purity
- 99.5%+
- Route
- Subcutaneous injection
- Storage
- Lyophilized: room temperature, desiccated. Reconstituted: 2–8°C, ≤30 days.
Compound profile
Human Chorionic Gonadotropin (HCG) is a 237-amino-acid heterodimeric glycoprotein hormone composed of an alpha subunit (shared with LH, FSH, and TSH) and a unique beta subunit that confers its biological specificity. HCG is naturally produced by trophoblast cells of the placenta during pregnancy, but its research significance lies in its near-identical structural and functional homology with luteinizing hormone (LH). HCG binds to and activates the LH/CG receptor on Leydig cells in the testes, directly stimulating testosterone biosynthesis through the cholesterol side-chain cleavage pathway, independent of the hypothalamic-pituitary axis.
Human Chorionic Gonadotropin (HCG) is a 237-amino-acid heterodimeric glycoprotein hormone composed of an alpha subunit (shared with LH, FSH, and TSH) and a unique beta subunit that confers its biological specificity. HCG is naturally produced by trophoblast cells of the placenta during pregnancy, but its research significance lies in its near-identical structural and functional homology with luteinizing hormone (LH). HCG binds to and activates the LH/CG receptor on Leydig cells in the testes, directly stimulating testosterone biosynthesis through the cholesterol side-chain cleavage pathway, independent of the hypothalamic-pituitary axis.
HCG's mechanism at the testicular level bypasses the HPG axis entirely. By directly binding LH receptors on Leydig cells, it activates adenylyl cyclase, increases cAMP, and upregulates the steroidogenic acute regulatory protein (StAR) that transports cholesterol into mitochondria for conversion to pregnenolone — the rate-limiting step in testosterone synthesis. This direct Leydig cell stimulation maintains intratesticular testosterone (ITT) at levels necessary for spermatogenesis, testicular volume, and Leydig cell viability even when exogenous androgen use has suppressed LH secretion from the pituitary. Without LH receptor stimulation, Leydig cells undergo progressive desensitization and atrophy, making HCG essential for preserving testicular function during protocols that suppress endogenous gonadotropins.
Research consistently demonstrates that HCG maintains testicular size, preserves intratesticular testosterone concentrations, supports spermatogenesis, and facilitates faster recovery of endogenous testosterone production when exogenous androgens are discontinued. It is the standard of care for preventing testicular atrophy during testosterone replacement therapy and is a foundational component of post-cycle therapy (PCT) protocols, where it is typically used as a "bridge" between the cessation of suppressive compounds and the initiation of SERM-based recovery.
HCG is suited for researchers investigating testicular function maintenance, HPG axis recovery, intratesticular testosterone dynamics, and reproductive hormone optimization. It is an essential compound for any research protocol involving suppressive hormonal compounds.
Reconstitute the 5000IU vial with 2.5ml bacteriostatic water (yielding 2000IU/ml). Administer via subcutaneous or intramuscular injection. On-cycle research dosing typically ranges from 250-500IU every other day or twice weekly. PCT bridge dosing may use 1000-1500IU every other day for 2-3 weeks before transitioning to SERMs. HCG has a half-life of approximately 24-36 hours. Store reconstituted solution at 2-8C and use within 30 days — HCG is a large glycoprotein that degrades relatively quickly in solution. Do not freeze reconstituted HCG. The lyophilized powder should be refrigerated.
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
HCG 5000IU is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water (BAC water) before use in a research setting.
- Clean the BAC water vial stopper and the peptide vial stopper with an alcohol swab. Allow to dry.
- Draw the required volume of BAC water into a sterile syringe (typically 1–3 mL depending on target concentration).
- Angle the needle so the water runs down the inside wall of the peptide vial. Avoid dispensing directly onto the powder.
- Do not shake. Gently swirl or roll until fully dissolved. Vigorous shaking can denature peptides.
- Refrigerate reconstituted solution at 2–8°C. Most reconstituted peptides are stable 14–30 days depending on compound.
Target concentration determines drawing volume. For dosing math, consult the dosing math guide.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
Read the research
Reference articles from the lab covering this compound.
beginner guides
Testosterone Enanthate Beginner Cycle: The Complete 12-Week Protocol
The complete testosterone enanthate beginner cycle guide. 12-week protocol with dosing, injection schedule, AI management, PCT, bloodwork timing, week-by-week results, and common mistakes to avoid.
best of
Best First Steroid Cycle 2026: The Only Protocol Beginners Should Run
The definitive beginner steroid cycle guide for 2026. Testosterone Enanthate 300-500mg/week for 12 weeks — why only testosterone, complete PCT, bloodwork, and what to expect.
compound guides
Blood Work for Steroid Users: What to Test, When & Why (Canadian Guide)
Complete guide to blood work for steroid users in Canada. Learn exactly which panels to run pre-cycle, mid-cycle, and post-PCT — plus where to get private bloodwork without a doctor's referral.
Complete the protocol
Reconstitution Kit — Standard
30ml bac water · 10 syringes · mixing syringe · swabs
4.9
